Skip to content

Clinical trials

Cardiotoxicity trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiotoxicity Country / region: China Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20141
20171
20194
20201
20214
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status10
Recruiting3
Completed2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking University Third Hospital3
Affiliated Hospital of Qinghai University1
Air Force Military Medical University, China1
First Hospital of China Medical University1
Fudan University1
Haiyan Li1
Kai Mu1
Peking University Cancer Hospital & Institute1
Qianfoshan Hospital1
Ruijin Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiotoxicity16
Breast Neoplasms4
Altitude Sickness1
Carcinoma, Non-Small-Cell Lung1
Long QT Syndrome1
Lymphoma1
Lymphoma, B-Cell1
Neoplasms1
Osteosarcoma1

Trials

Showing 26 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.